National Pension Service’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $237M | Buy |
379,815
+8,264
| +2% | +$5.63M | 0.15% | 142 |
|
|
2026
Q1 | $287M | Buy |
371,551
+10,563
| +3% | +$8.09M | 0.22% | 106 |
|
|
2025
Q4 | $279M | Buy |
360,988
+82,853
| +30% | +$56.3M | 0.21% | 110 |
|
|
2025
Q3 | $156M | Buy |
278,135
+7,069
| +3% | +$4M | 0.12% | 189 |
|
|
2025
Q2 | $142M | Buy |
271,066
+18,020
| +7% | +$10.1M | 0.12% | 192 |
|
|
2025
Q1 | $160M | Buy |
253,046
+20,596
| +9% | +$14.2M | 0.15% | 158 |
|
|
2024
Q4 | $166M | Buy |
232,450
+8,833
| +4% | +$7.41M | 0.16% | 146 |
|
|
2024
Q3 | $235M | Buy |
223,617
+32,457
| +17% | +$36.1M | 0.23% | 93 |
|
|
2024
Q2 | $201M | Buy |
191,160
+3,411
| +2% | +$3.31M | 0.23% | 85 |
|
|
2024
Q1 | $181M | Buy |
187,749
+1,439
| +0.8% | +$1.37M | 0.22% | 100 |
|
|
2023
Q4 | $164M | Buy |
186,310
+3,887
| +2% | +$3.2M | 0.23% | 96 |
|
|
2023
Q3 | $152M | Buy |
182,423
+3,212
| +2% | +$2.52M | 0.24% | 90 |
|
|
2023
Q2 | $127M | Sell |
179,211
-5,963
| -3% | -$4.6M | 0.2% | 109 |
|
|
2023
Q1 | $150M | Buy |
185,174
+3,386
| +2% | +$2.55M | 0.27% | 82 |
|
|
2022
Q4 | $131M | Buy |
181,788
+2,131
| +1% | +$1.57M | 0.26% | 88 |
|
|
2022
Q3 | $124M | Buy |
179,657
+7,074
| +4% | +$4.45M | 0.26% | 80 |
|
|
2022
Q2 | $102M | Buy |
172,583
+15,135
| +10% | +$9.84M | 0.21% | 105 |
|
|
2022
Q1 | $110M | Buy |
157,448
+1,906
| +1% | +$1.21M | 0.2% | 106 |
|
|
2021
Q4 | $98.2M | Sell |
155,542
-3,927
| -2% | -$2.41M | 0.17% | 126 |
|
|
2021
Q3 | $96.5M | Sell |
159,469
-1,501
| -0.9% | -$932K | 0.18% | 119 |
|
|
2021
Q2 | $89.9M | Buy |
160,970
+2,553
| +2% | +$1.29M | 0.17% | 130 |
|
|
2021
Q1 | $75M | Buy |
158,417
+13,314
| +9% | +$6.48M | 0.16% | 146 |
|
|
2020
Q4 | $70.1M | Buy |
145,103
+13,101
| +10% | +$7.07M | 0.16% | 140 |
|
|
2020
Q3 | $75.5M | Hold |
132,002
| – | – | 0.2% | 118 |
|
|
2020
Q2 | $82.3M | Buy |
132,002
+3,482
| +3% | +$1.98M | 0.24% | 90 |
|
|
2020
Q1 | $62.8M | Buy |
128,520
+2,716
| +2% | +$1.12M | 0.21% | 115 |
|
|
2019
Q4 | $47.2M | Buy |
125,804
+19,021
| +18% | +$6.4M | 0.13% | 198 |
|
|
2019
Q3 | $29.6M | Buy |
106,783
+4,867
| +5% | +$1.44M | 0.09% | 270 |
|
|
2019
Q2 | $31.9M | Buy |
101,916
+10,084
| +11% | +$3.36M | 0.11% | 248 |
|
|
2019
Q1 | $37.7M | Buy |
91,832
+3,422
| +4% | +$1.41M | 0.15% | 172 |
|
|
2018
Q4 | $36.7M | Buy |
88,410
+4,075
| +5% | +$1.49M | 0.15% | 166 |
|
|
2018
Q3 | $34.1M | Sell |
84,335
-250
| -0.3% | -$95.1K | 0.14% | 178 |
|
|
2018
Q2 | $28.9M | Buy |
84,585
+6,301
| +8% | +$1.97M | 0.13% | 194 |
|
|
2018
Q1 | $27M | Buy |
78,284
+6,275
| +9% | +$2.18M | 0.13% | 193 |
|
|
2017
Q4 | $27.1M | Buy |
72,009
+2,763
| +4% | +$1.12M | 0.14% | 196 |
|
|
2017
Q3 | $30.1M | Buy |
69,246
+2,728
| +4% | +$1.3M | 0.17% | 162 |
|
|
2017
Q2 | $33.9M | Buy |
66,518
+6,481
| +11% | +$2.84M | 0.2% | 121 |
|
|
2017
Q1 | $23.2M | Buy |
60,037
+3,430
| +6% | +$1.27M | 0.16% | 168 |
|
|
2016
Q4 | $20.8M | Buy |
56,607
+4,501
| +9% | +$1.71M | 0.14% | 196 |
|
|
2016
Q3 | $20.9M | Buy |
52,106
+4,240
| +9% | +$1.7M | 0.17% | 155 |
|
|
2016
Q2 | $16.7M | Buy |
47,866
+5,634
| +13% | +$2.17M | 0.15% | 183 |
|
|
2016
Q1 | $15.2M | Buy |
42,232
+1,620
| +4% | +$668K | 0.15% | 170 |
|
|
2015
Q4 | $22M | Buy |
40,612
+2,420
| +6% | +$1.31M | 0.23% | 108 |
|
|
2015
Q3 | $17.8M | Buy |
38,192
+4,574
| +14% | +$2.46M | 0.22% | 118 |
|
|
2015
Q2 | $17.1M | Buy |
33,618
+4,862
| +17% | +$2.37M | 0.22% | 113 |
|
|
2015
Q1 | $13M | Buy |
28,756
+3,108
| +12% | +$1.32M | 0.19% | 138 |
|
|
2014
Q4 | $10.5M | Sell |
25,648
-2,752
| -10% | -$1.08M | 0.18% | 148 |
|
|
2014
Q3 | $10.2M | Buy |
+28,400
| New | +$9.52M | 0.16% | 170 |
|
Other funds holding REGN
VCM
VPM
N
National Pension Service's REGN Position: Q2 2026 in Review
National Pension Service increased its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q2 2026, buying an estimated $5.63M and bringing the position to 379,815 shares worth $237M. The position accounts for 0.15% of the portfolio, ranked #142.
National Pension Service first reported a position in REGN in Q3 2014 and has held it in 48 quarters since. The position peaked at $287M in Q1 2026. 1,073 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- National Pension Service held 379,815 shares of Regeneron Pharmaceuticals worth $237M as of Q2 2026.
- National Pension Service bought 8,264 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.63M.
- Regeneron Pharmaceuticals made up 0.15% of National Pension Service's portfolio in Q2 2026, its #142 holding.
- National Pension Service first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 48 quarters since.
- National Pension Service's Regeneron Pharmaceuticals position peaked at $287M in Q1 2026.
- 1,073 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on National Pension Service's 13F filing for Q2 2026, filed 13 Aug 2026.